Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.22 USD | +1.67% | +4.92% | -11.18% |
May. 10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |